ISO 15189:2022 - Medical Laboratories Internal Auditor Free Practice Test — 30 Questions

Question 1

An internal auditor is reviewing the laboratory information management system (LIMS) at a clinical diagnostics facility. The auditor notes that while the LIMS effectively manages patient data and test results, there are no documented procedures for regular system validation or comprehensive audit trails for data modifications. The laboratory director states that the system was purchased from a reputable vendor and is widely used in the industry. Which of the following findings would represent the most significant non-conformity with ISO 15189:2022 requirements regarding data integrity and system management?

Accepted Answer

Lack of documented validation of the LIMS and absence of a comprehensive audit trail for data alterations.

Question 2

An internal auditor reviewing the quality management system of a clinical pathology laboratory discovers a recurring pattern of minor deviations in the calibration of a specific immunoassay analyzer over the past three audit cycles. While each individual deviation was addressed by re-calibrating the instrument and documenting the event, no overarching investigation into the underlying causes of these repeated occurrences has been initiated. Which of the following actions by the internal auditor best reflects the requirements of ISO 15189:2022 regarding the management of nonconforming work and the pursuit of continual improvement?

Accepted Answer

Recommend that the laboratory implement a formal root cause analysis for the recurring calibration deviations and ensure that corrective actions are taken to prevent future occurrences, verifying the effectiveness of these actions.

Question 3

During an internal audit of a clinical chemistry department, an auditor discovers that several patient results for a specific analyte were reported with a delay exceeding the laboratory\'s stated turnaround time (TAT) target for critical values. The auditor notes that the laboratory director was informed of the delays, and the affected staff were reminded of the TAT policy. What is the most appropriate next step for the internal auditor to ensure the non-conformity is effectively addressed according to ISO 15189:2022 principles?

Accepted Answer

Verify that a root cause analysis has been initiated and that a plan for corrective actions to prevent recurrence has been developed and is being implemented.

Question 4

During an internal audit of a clinical chemistry laboratory, it was discovered that a critical analyte\'s quality control (QC) samples for the morning run consistently yielded results outside the established Westgard rules. The laboratory supervisor indicated that the instrument was recalibrated, and subsequent QC runs met specifications. However, patient samples processed during the period of QC failure had already been reported. What is the most critical action the internal auditor should verify to ensure compliance with ISO 15189:2022 requirements for result validity?

Accepted Answer

Confirmation that a documented procedure exists and was followed to identify, quarantine, and re-examine all patient samples tested during the period of QC failure, and that these samples were only re-reported after the QC system was demonstrably back in control.

Question 5

During an internal audit of a clinical chemistry laboratory, it was discovered that a critical reagent for a specific immunoassay was inadvertently prepared using a slightly higher concentration of buffer than specified in the standard operating procedure. The deviation was identified immediately after preparation, and the reagent was not yet used for patient sample analysis. What is the most appropriate course of action for the laboratory to ensure the validity of results if this reagent were to be used, according to ISO 15189:2022 requirements?

Accepted Answer

Document the deviation, assess the potential impact of the higher buffer concentration on assay performance, implement corrective actions if necessary, and validate the reagent's performance before use.

Question 6

During an internal audit of a clinical pathology laboratory accredited to ISO 15189:2022, an auditor observes that a batch of patient samples collected from a remote clinic experienced a 3-hour delay in reaching the laboratory due to unforeseen logistical issues. The laboratory\'s documented procedure for sample transport specifies a maximum transit time of 4 hours. While the samples were eventually processed and yielded results, the auditor is concerned about the potential impact on sample integrity and the laboratory\'s ability to consistently meet pre-examination requirements. What is the most appropriate focus for the internal audit finding related to this observation?

Accepted Answer

Evaluate the effectiveness of the laboratory's sample transport validation and monitoring processes to ensure continued sample integrity.

Question 7

Consider a scenario where an internal audit at a clinical pathology laboratory reveals that a batch of patient samples for a specific immunoassay test yielded results outside the expected analytical range, and subsequent internal quality control checks also failed. The laboratory director immediately halts the release of any results from that batch and initiates an investigation. Which of the following actions, as per ISO 15189:2022, represents the most comprehensive and compliant response to this non-conforming examination?

Accepted Answer

Segregate the affected samples and associated data, conduct a root cause analysis, implement corrective actions to address the identified cause, and verify the effectiveness of these actions.

Question 8

During an internal audit of a clinical pathology laboratory accredited to ISO 15189:2022, an auditor is reviewing the process for handling non-conforming examinations. The laboratory\'s procedure dictates that any result falling outside predefined analytical performance specifications must be immediately flagged, re-tested by a different analyst using a separate aliquot, and if the discrepancy persists, the original sample is quarantined while a root cause analysis is initiated. The auditor finds a record where a critical chemistry result was flagged due to an analytical deviation. The re-test confirmed the deviation, but the original sample was released for reporting after a verbal confirmation from the requesting physician, without a formal documented review of the root cause or a decision on corrective action. Which of the following best reflects the auditor\'s finding regarding the laboratory\'s adherence to ISO 15189:2022 requirements for non-conforming examinations?

Accepted Answer

The laboratory failed to adequately control the non-conforming examination by releasing the result without completing the documented root cause analysis and corrective action process, potentially impacting patient care and the integrity of the QMS.

Question 9

An internal auditor for a clinical pathology laboratory, operating under ISO 15189:2022 accreditation, is reviewing the personnel files for technologists performing a newly implemented, complex immunoassay. The auditor notes that one technologist, while possessing extensive general experience in immunoassay techniques, has not yet completed the specific training module and competency assessment for this particular new assay. What is the most critical finding for the auditor to document regarding this technologist\'s adherence to personnel competence requirements?

Accepted Answer

The technologist has not completed the documented training and competency assessment specifically for the new immunoassay.

Question 10

A medical laboratory\'s internal quality control for a specific biochemical assay consistently shows results within the acceptable range. However, during the most recent external quality assessment (EQA) proficiency testing round for the same analyte, the laboratory receives a failing score. What is the most appropriate immediate action for the laboratory to take, considering the requirements of ISO 15189:2022 regarding result validity and quality assurance?

Accepted Answer

Immediately investigate the analytical system, identify the root cause of the EQA failure, implement corrective actions, and re-evaluate all patient results generated during the period of potential analytical system compromise indicated by the IQC and EQA data.

Question 11

During an internal audit of a medical laboratory accredited to ISO 15189:2022, an auditor reviews the process for handling patient samples referred to external facilities for specialized testing. The laboratory director states that they trust the quality of these external laboratories based on informal discussions. Which of the following findings would represent the most significant deficiency concerning the laboratory\'s compliance with the standard\'s requirements for referral testing?

Accepted Answer

The absence of a documented procedure for the selection, evaluation, and ongoing monitoring of referral laboratories, including established criteria for their competence and quality assurance.

Question 12

During an internal audit of a clinical chemistry laboratory operating under ISO 15189:2022, an auditor observes that the internal quality control (IQC) data for a specific biochemical marker, \"Analyte X,\" has consistently fallen within the laboratory\'s established acceptable ranges for the past three months. However, the laboratory\'s participation in a relevant external quality assessment (EQA) scheme for Analyte X shows that their results have been consistently below the peer group\'s mean and outside the acceptable performance limits for the same period. What is the most appropriate immediate action for the internal auditor to recommend to the laboratory management regarding the release of patient results for Analyte X?

Accepted Answer

Immediately suspend the release of all patient results for Analyte X until the discrepancy between IQC and EQA performance is investigated and resolved.

Question 13

During an internal audit of a medical laboratory\'s hematology section, the auditor observes that the IQC for a specific coagulation parameter has consistently yielded results at the upper boundary of the established acceptable range for the past three months. Concurrently, the laboratory\'s participation in the relevant external quality assessment (EQA) scheme for this parameter has consistently demonstrated satisfactory performance, with results falling within the acceptable peer group limits. Considering the principles of ISO 15189:2022 and the need to ensure the ongoing validity of results, what is the most critical action for the internal auditor to take in this situation?

Accepted Answer

Verify the laboratory has a documented procedure for reviewing IQC trends, investigating deviations, and implementing corrective actions, including the rationale for maintaining current IQC limits.

Question 14

An internal audit of a clinical chemistry laboratory reveals that a recently implemented automated immunoassay analyzer for a novel biomarker has not undergone a formal, documented performance verification process beyond the manufacturer\'s basic installation qualification. The laboratory director states that the initial results appear consistent with preliminary research findings and that the instrument is functioning as expected. As an internal auditor, what is the most critical recommendation to ensure compliance with ISO 15189:2022 and to safeguard the integrity of patient results?

Accepted Answer

Implement a comprehensive, documented verification of the analytical procedure's performance characteristics, including accuracy, precision, linearity, and analytical specificity, prior to its routine clinical use.

Question 15

An internal auditor is reviewing the laboratory information management system (LIMS) at a clinical diagnostics facility. During the audit, it is discovered that while the LIMS is currently in use for daily operations, there is no documented evidence of a formal validation process having been completed for the system\'s current configuration. What is the most appropriate course of action for the internal auditor to recommend regarding this finding, considering the requirements of ISO 15189:2022?

Accepted Answer

Classify the lack of LIMS validation as a major non-conformity and require immediate corrective action to implement a validation process.

Question 16

An internal audit at a clinical pathology laboratory reveals that a critical diagnostic test result for a patient, Mr. Alistair Finch, was initially reported with an error due to a calibration issue with a specific instrument. The laboratory\'s quality manager states that the issue was identified internally, corrected, and a corrected report was issued to the referring physician. However, the auditor is concerned about the process for determining if the patient or referring physician had already acted upon the incorrect result. Which of the following best describes the auditor\'s primary focus when evaluating the laboratory\'s response to this nonconforming work, according to ISO 15189:2022?

Accepted Answer

Verifying the existence and adequacy of documented procedures for managing nonconforming work, including the assessment of impact and communication of corrections to relevant parties, and reviewing records to confirm their consistent application.

Question 17

During an internal audit of a medical laboratory accredited to ISO 15189:2022, an auditor identifies a critical result for a patient that was not communicated to the requesting physician within the laboratory\'s defined critical value reporting timeframe. The laboratory has a documented procedure for critical value reporting. What is the primary focus of the internal auditor\'s follow-up action regarding this nonconformity?

Accepted Answer

Assess the effectiveness of the laboratory's corrective and preventive action (CAPA) process in addressing the root cause of the delayed critical result communication and preventing recurrence.

Question 18

During an internal audit of a medical laboratory accredited to ISO 15189:2022, an auditor discovers a recurring issue where patient sample identification discrepancies are noted in the pre-analytical phase, leading to potential misreporting. The laboratory has documented these instances in their nonconformity log. What is the most critical subsequent action the internal auditor must undertake to ensure the effectiveness of the laboratory\'s quality management system in relation to this finding?

Accepted Answer

Verify that the laboratory has implemented corrective actions addressing the identified root cause(s) of the sample identification discrepancies and assess the effectiveness of these actions in preventing recurrence.

Question 19

When conducting an internal audit of a medical laboratory\'s quality management system, an auditor is reviewing the process for handling laboratory results that do not meet established acceptance criteria or are otherwise deemed non-conforming. What is the primary focus of the auditor\'s verification concerning these non-conforming outputs?

Accepted Answer

Confirmation that a documented procedure exists and is being followed for the identification, segregation, evaluation, and disposition of non-conforming outputs, including appropriate record-keeping.

Question 20

During an internal audit of a clinical chemistry laboratory, an auditor observes that the temperature log for a refrigerator storing a critical reagent used in a high-volume diagnostic assay has not been consistently maintained with validated entries for the past two weeks. The laboratory\'s standard operating procedure requires daily temperature monitoring and recording, with any deviation outside the validated range to be immediately investigated and documented. The reagent\'s stability is directly dependent on maintaining the specified temperature range. Which of the following findings constitutes a significant nonconformity requiring immediate attention and reporting according to ISO 15189:2022 principles for internal auditors?

Accepted Answer

Failure to maintain validated temperature records for a critical reagent storage unit, potentially compromising reagent stability and test result accuracy.

Question 21

During an internal audit of a clinical chemistry section, an auditor discovers that a critical reagent lot, used for a high-volume assay, was inadvertently used past its expiry date due to a failure in the inventory management system\'s expiry date flagging. The laboratory director acknowledges the oversight and states that the affected patient results have been reviewed and no significant impact was identified. What is the most appropriate immediate follow-up action for the internal auditor to verify the laboratory\'s compliance with ISO 15189:2022 regarding this nonconformity?

Accepted Answer

Confirm that the laboratory has initiated a process to identify the root cause of the inventory management system failure and has planned or implemented corrective actions to prevent recurrence.

Question 22

When conducting an internal audit of a medical laboratory\'s quality management system according to ISO 15189:2022, what is the primary objective when assessing the laboratory\'s risk management framework?

Accepted Answer

To verify that the laboratory has a systematic process for identifying, analyzing, evaluating, and controlling risks that could affect the quality of laboratory services and patient safety.

Question 23

During an internal audit of a clinical chemistry laboratory that has recently implemented a novel immunoassay for a specific biomarker, the auditor is reviewing the process for introducing this new analytical method. The laboratory director states that the method has been thoroughly validated and is now in routine use. What is the primary focus of the internal auditor\'s verification regarding this new method\'s implementation, as per ISO 15189:2022 requirements?

Accepted Answer

Reviewing the validation study documentation to confirm that evidence demonstrates the method's fitness for purpose and that associated risks were adequately managed.

Question 24

During an internal audit of a medical laboratory accredited to ISO 15189:2022, an auditor discovers a recurring discrepancy in the calibration of a critical analytical instrument, leading to a series of out-of-specification results for a specific analyte. The laboratory has documented corrective actions for each instance, but the problem persists. What is the primary focus of the internal auditor\'s evaluation in this scenario, considering the standard\'s requirements for managing non-conformities and ensuring ongoing quality?

Accepted Answer

Assessing the laboratory's process for root cause analysis and the effectiveness of implemented corrective and preventive actions to address the recurring instrument calibration issue.

Question 25

During an internal audit of a medical laboratory accredited to ISO 15189:2022, an auditor discovers a critical result for a patient was incorrectly reported due to a validated assay performing outside its established analytical performance specifications, a fact that was not detected by the laboratory\'s quality control procedures at the time of reporting. The report was subsequently corrected and reissued. What is the most critical aspect for the internal auditor to focus on in their report regarding this incident?

Accepted Answer

The effectiveness of the laboratory's established procedures for handling nonconforming work and the subsequent corrective actions taken.

Question 26

During an internal audit of a clinical pathology laboratory, an auditor is reviewing the process for handling specimens that do not meet the laboratory\'s acceptance criteria for testing. The laboratory has identified several instances where critical patient samples were processed despite minor deviations from standard operating procedures, with the rationale being that the delay in re-collection would be detrimental to patient care. What is the most appropriate approach for the internal auditor to assess the laboratory\'s adherence to ISO 15189:2022 requirements concerning non-conforming work?

Accepted Answer

Review the documented procedure for handling non-conforming work and audit the implementation to ensure identified non-conforming samples are appropriately segregated, evaluated, and their disposition is documented and justified.

Question 27

During an internal audit of a clinical laboratory, an auditor is examining the process for introducing a new immunoassay for a specific biomarker. The laboratory has completed the analytical validation of this new method. What is the primary focus for the internal auditor when assessing the laboratory\'s compliance with ISO 15189:2022 regarding this new method\'s implementation?

Accepted Answer

Reviewing the documented validation and verification data to ensure it meets the laboratory's defined acceptance criteria and demonstrates fitness for purpose.

Question 28

Following an internal audit that identified a critical nonconformity in the pre-analytical phase concerning sample integrity checks, the laboratory director has initiated a corrective action plan. The plan includes retraining staff on sample handling protocols and implementing a new visual inspection checklist for all incoming specimens. What is the most critical subsequent step for the internal audit team to ensure the effectiveness of the implemented corrective actions and adherence to ISO 15189:2022 principles?

Accepted Answer

Verify the effectiveness of the implemented corrective actions through follow-up audits and review of associated documentation.

Question 29

An internal auditor is tasked with evaluating the laboratory\'s adherence to personnel competence requirements as outlined in ISO 15189:2022. The auditor is reviewing the process for ensuring that all staff involved in pre-examination, examination, and post-examination activities possess the necessary skills and knowledge. Which of the following audit approaches would most effectively demonstrate the laboratory\'s compliance with the standard\'s intent regarding personnel competence?

Accepted Answer

Reviewing documented evidence of initial competency assessments for all personnel, coupled with ongoing performance monitoring records and documented training relevant to their roles across all testing phases.

Question 30

During an internal audit of a clinical pathology laboratory accredited to ISO 15189:2022, an auditor observes that the documented procedure for patient sample collection and identification, specifically the verification of patient wristbands against requisition forms, is missing a critical step for pediatric inpatients. This step, which involves a secondary verbal confirmation with a nurse or guardian if the patient is unable to confirm their identity, is not detailed in the existing standard operating procedure (SOP). The laboratory has experienced two instances in the past year where samples were misidentified, although no adverse patient outcomes were reported. What is the most appropriate immediate action for the internal auditor to take regarding this observation?

Accepted Answer

Document the observation as a non-conformity against the laboratory's quality management system and the requirements of ISO 15189:2022, highlighting the absence of a defined procedure for a critical pre-analytical step.

ISO 15189:2022 - Medical Laboratories Internal Auditor Free Practice Test — 30 Questions

A lot more is already mapped out

About the ISO 15189:2022 - Medical Laboratories Internal Auditor Certification